Karriereverlauf von Daniela Oniciu
Ehemalige bekannte Positionen von Daniela Oniciu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OCUPHIRE PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | 31.12.2023 |
| NEUROBO PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2014 | 01.11.2018 |
| ABIONYX PHARMA | Corporate Officer/Principal | 24.02.2010 | 01.02.2014 |
| PFIZER, INC. | Corporate Officer/Principal | 01.12.2004 | 01.02.2008 |
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | 01.02.2001 | 01.01.2004 |
| Creative Pharma Advisors LLC | Gründer | - | - |
BioSavita, Inc.
 BioSavita, Inc. BiotechnologyHealth Technology BioSavita, Inc. operates as a biotechnology company, which develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company was founded by Nalini Ghag-Motwani in 1993 and is headquartered in Plymouth, MI. | Geschäftsführer | - | - |
Ausbildung von Daniela Oniciu
| Politehnica University of Bucharest | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Frankreich | 2 |
| Rumänien | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ABIONYX PHARMA | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| OCUPHIRE PHARMA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
BioSavita, Inc.
BioSavita, Inc. BiotechnologyHealth Technology BioSavita, Inc. operates as a biotechnology company, which develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company was founded by Nalini Ghag-Motwani in 1993 and is headquartered in Plymouth, MI. | Health Technology |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
| Creative Pharma Advisors LLC |
- Börse
- Insiders
- Daniela Oniciu
- Erfahrung
